Your browser doesn't support javascript.
loading
Candidate CSPG4 mutations and induced pluripotent stem cell modeling implicate oligodendrocyte progenitor cell dysfunction in familial schizophrenia.
de Vrij, Femke M; Bouwkamp, Christian G; Gunhanlar, Nilhan; Shpak, Guy; Lendemeijer, Bas; Baghdadi, Maarouf; Gopalakrishna, Shreekara; Ghazvini, Mehrnaz; Li, Tracy M; Quadri, Marialuisa; Olgiati, Simone; Breedveld, Guido J; Coesmans, Michiel; Mientjes, Edwin; de Wit, Ton; Verheijen, Frans W; Beverloo, H Berna; Cohen, Dan; Kok, Rob M; Bakker, P Roberto; Nijburg, Aviva; Spijker, Annet T; Haffmans, P M Judith; Hoencamp, Erik; Bergink, Veerle; Vorstman, Jacob A; Wu, Timothy; Olde Loohuis, Loes M; Amin, Najaf; Langen, Carolyn D; Hofman, Albert; Hoogendijk, Witte J; van Duijn, Cornelia M; Ikram, M Arfan; Vernooij, Meike W; Tiemeier, Henning; Uitterlinden, André G; Elgersma, Ype; Distel, Ben; Gribnau, Joost; White, Tonya; Bonifati, Vincenzo; Kushner, Steven A.
  • de Vrij FM; Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Bouwkamp CG; Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Gunhanlar N; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Shpak G; Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Lendemeijer B; Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Baghdadi M; Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Gopalakrishna S; Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Ghazvini M; Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Li TM; Department of Developmental Biology, and Erasmus MC iPS Facility, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Quadri M; Department of Developmental Biology, and Erasmus MC iPS Facility, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Olgiati S; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Breedveld GJ; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Coesmans M; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Mientjes E; Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands.
  • de Wit T; Delta Psychiatric Center, Poortugaal, The Netherlands.
  • Verheijen FW; Department of Neuroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Beverloo HB; ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Cohen D; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Kok RM; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Bakker PR; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Nijburg A; Mental Health Care Organization North-Holland North, Heerhugowaard, The Netherlands.
  • Spijker AT; Parnassia Psychiatric Institute, The Hague, The Netherlands.
  • Haffmans PMJ; Department of Psychiatry and Psychology, School of Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Hoencamp E; Psychiatric Center GGZ Centraal, Amersfoort, The Netherlands.
  • Bergink V; Parnassia Psychiatric Institute, The Hague, The Netherlands.
  • Vorstman JA; Faculty of Social and Behavioral Sciences Clinical, Health and Neuro Psychology, Department of Affective Disorders, PsyQ, Leiden University, Leiden, The Netherlands.
  • Wu T; Parnassia Psychiatric Institute, The Hague, The Netherlands.
  • Olde Loohuis LM; Institute of Psychology, Leiden University, Leiden, The Netherlands.
  • Amin N; Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Hofman A; Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Hoogendijk WJ; Department of Psychiatry, The Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.
  • van Duijn CM; Program in Genetics and Genome Biology, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Ikram MA; Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.
  • Vernooij MW; Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.
  • Tiemeier H; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Uitterlinden AG; Department of Radiology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Elgersma Y; Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Distel B; Biomedical Imaging Group Rotterdam, Departments of Radiology & Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Gribnau J; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • White T; Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Bonifati V; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Kushner SA; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Mol Psychiatry ; 24(5): 757-771, 2019 05.
Article en En | MEDLINE | ID: mdl-29302076

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteoglicanos Tipo Condroitín Sulfato / Esquizofrenia / Células Precursoras de Oligodendrocitos / Proteínas de la Membrana Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteoglicanos Tipo Condroitín Sulfato / Esquizofrenia / Células Precursoras de Oligodendrocitos / Proteínas de la Membrana Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article